Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2520PDF: 1950HTML: 1095 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2727PDF: 928HTML: 9080Efremov 1: 281Efremov 2: 251 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5239PDF: 3034HTML: 2387 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3655PDF: 1499HTML: 2752 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3332PDF: 980HTML: 7327Kost Fig1: 236Kost Fig 2: 222Kost Fig3: 243Kost Fig 4: 249Kost Fig5: 246Kost fig 6: 235 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2426PDF: 961HTML: 2037Fig 1 Rossi: 254 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1543PDF: 883HTML: 1043 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2763PDF: 960HTML: 17627Fig1 Caligaris: 246Fig.2 Caliga: 282 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3527PDF: 1038HTML: 4986 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4244PDF: 1665HTML: 9332Untitled: 352Untitled: 233Untitled: 219Untitled: 236Untitled: 234Untitled: 397 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1943PDF: 1280HTML: 372 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3123PDF: 1114HTML: 5678 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2529PDF: 1414HTML: 17245Bassan Fig.1: 188Bassan Fig.2: 293Bassan Fig.4: 177Fig.3: 315 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4829PDF: 3970HTML: 383 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4506PDF: 2061HTML: 5573Table 1: 305 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3965PDF: 1750HTML: 116 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1774PDF: 714HTML: 2457 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1831PDF: 1179HTML: 201 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2449PDF: 1143HTML: 2041Characteristic of study group: 267 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1775HTML: 727PDF: 934 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1290PDF: 681Suppl. Files: 156HTML: 554 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4742PDF: 1835HTML: 1405 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2470PDF: 1096HTML: 7723Untitled: 332Fig2: 236Fig3: 228Fig4: 254 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3511PDF: 998HTML: 1564Fig.1 CHL-R paper: 271Fig 2 CHL-R paper: 313 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2155PDF: 901HTML: 273 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3979PDF: 1722HTML: 894Figures . Eliassian: 336 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1658PDF: 1042HTML: 274 -
Osteolytic bone lesions – A rare presentation of AML M6.
2139PDF: 1232HTML: 8029Untitled: 257







